About Nervonic Acid
Nervonic acid (24:1 n-9) is a very-long-chain monounsaturated omega-9 fatty acid concentrated in nervous-tissue myelin (sphingolipids). It is marketed for brain and myelin health on mechanistic grounds and animal/demyelination models; robust human clinical trials are lacking. Grades low (mechanistic and preclinical evidence only).
What Nervonic Acid supports
- A component of nerve myelin, studied for brain and nerve health mainly in animals and cell models, not human trials
How much Nervonic Acid to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
0–0
mg
No established therapeutic dose. Nominal range for a fatty-acid-profile line item.
Clinical evidence
Limited clinical evidence. Mechanistic/preclinical (myelin) only; no robust human trials.